Target intelligence / Profile preview

Innate immune sensing pathways engaged by aluminium adjuvant

Molecular classification
Signaling pathway, Innate immune sensing system
01

Overview

Innate immune sensing pathways engaged by aluminium adjuvant refer to the complex molecular mechanisms through which aluminum salts (alum) enhance the body's immune response to vaccine antigens. Alum acts as a potent activator of the innate immune system by triggering several distinct pathways, most notably the NLRP3 inflammasome. Upon phagocytosis, alum particles cause lysosomal destabilization and the release of cathepsin B, which leads to the assembly of the NLRP3 inflammasome, activation of caspase-1, and the secretion of pro-inflammatory cytokines IL-1β and IL-18. Additionally, alum induces the release of damage-associated molecular patterns (DAMPs) such as host DNA and uric acid, which are sensed by the cGAS-STING pathway and contribute to dendritic cell maturation and Th2-biased adaptive immunity. Alum also interacts directly with cell membrane lipid rafts to activate Syk and PI3K signaling pathways, further promoting antigen uptake and presentation. While highly effective for enhancing antibody production, these pathways are also associated with local inflammation and rare systemic safety concerns.

Other names
Alum-induced innate immune pathwaysAluminium adjuvant sensingNLRP3 inflammasome activation by alumSyk-dependent alum sensingDAMP-mediated alum sensing
02

Mechanism of action

Activation of the NLRP3 inflammasome via lysosomal destabilization; induction of DAMP release (DNA, uric acid); activation of Syk kinase and PI3K signaling.

03

Biological functions

Immune responseSignal transductionInflammationAntigen presentationTh2 cell differentiation
04

Disease associations

InfectionInflammationAutoimmunity
05

Safety considerations

Injection site reactions (redness, swelling, pain)Granuloma formationPersistent subcutaneous nodulesAutoimmune/inflammatory syndrome induced by adjuvants (ASIA)
06

Interacting drugs

Aluminium hydroxide

4 more in the full profile.

07

Biomarkers

Interleukin-1 beta (IL-1β)Interleukin-18 (IL-18)Caspase-1Uric acidExtracellular DNA

Beyond the preview

Go deeper on Innate immune sensing pathways engaged by aluminium adjuvant.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innate immune sensing pathways engaged by aluminium adjuvant.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call